You just read:

Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS)

News provided by

Biocept, Inc.

Mar 14, 2017, 08:05 ET